Search Results 21-30 of 16464 for Scleroderma
The purpose of this study is to find out whether BI 685509 helps people with scleroderma who have symptoms due to lung fibrosis or vascular problems.
Clinical Trials · A Study to Evaluate the Safety and Tolerability of Oral Ixazomib in Scleroderma-related Lung Disease Patients · More about research at Mayo ...
Mixed connective tissue disease (MCTD) has signs and symptoms of a combination of disorders — primarily lupus, scleroderma, and polymyositis. Many people ...
A Trial to Compare Nintedanib With Placebo for Patients With Scleroderma Related Lung Fibrosis. Print details. Share; Facebook · Twitter. Overview ...
Scleroderma causes hardening of the skin and the body's connective tissues, and it can damage internal organs. A biopsy may be performed to rule out other ...
A Trial to Evaluate the Safety of Long Term Treatment With Nintedanib in Patients With Scleroderma Related Lung Fibrosis · More about research at Mayo Clinic.
Nephrogenic systemic fibrosis may resemble skin diseases, such as scleroderma and scleromyxedema, with thickening and darkening developing on large areas of the ...
A condition that causes the skin to harden and tighten, called scleroderma. Nervous system diseases, such as migraine, Parkinson's disease or multiple ...
The purpose of this study is to assess known gene variants in a patient with associated pulmonary arterial hypertension (PAH) due to scleroderma who is ...
Examples include lupus, rheumatoid arthritis and scleroderma. Sex. Giant cell arteritis is much more common in women, while Buerger's disease is more common ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.